Functional Dyspepsia Drug Market, Global Outlook and Forecast 2023-2029

Functional dyspepsia, also known as non-ulcer dyspepsia or indigestion, is a term used to describe a group of symptoms affecting the gastrointestinal tract, including stomach pain or discomfort, nausea, bloating and belching. The condition is diagnosed when no obvious cause can be found for the symptoms present, though a small percentage of cases are caused by infection with the germ Helicobacter pylori.
This report aims to provide a comprehensive presentation of the global market for Functional Dyspepsia Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Functional Dyspepsia Drug. This report contains market size and forecasts of Functional Dyspepsia Drug in global, including the following market information:
Global Functional Dyspepsia Drug Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Functional Dyspepsia Drug Market Sales, 2018-2023, 2024-2029, (M Units)
Global top five Functional Dyspepsia Drug companies in 2022 (%)
The global Functional Dyspepsia Drug market was valued at US$ 6121.1 million in 2022 and is projected to reach US$ 7365.8 million by 2029, at a CAGR of 2.7% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North America is the largest consumer of Functional Dyspepsia Drug in global market, with a consumption market share of 38.71% in 2019. Market is not concentrated.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Functional Dyspepsia Drug manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Functional Dyspepsia Drug Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (M Units)
Global Functional Dyspepsia Drug Market Segment Percentages, by Type, 2022 (%)
    Prokinetic Drugs
    Gastric Antisecretory Drugs
    Others
Global Functional Dyspepsia Drug Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (M Units)
Global Functional Dyspepsia Drug Market Segment Percentages, by Application, 2022 (%)
    Hospitals
    Drugstores
Global Functional Dyspepsia Drug Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (M Units)
Global Functional Dyspepsia Drug Market Segment Percentages, By Region and Country, 2022 (%)
    North America
        US
        Canada
        Mexico
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
        Nordic Countries
        Benelux
        Rest of Europe
    Asia
        China
        Japan
        South Korea
        Southeast Asia
        India
        Rest of Asia
    South America
        Brazil
        Argentina
        Rest of South America
    Middle East & Africa
        Turkey
        Israel
        Saudi Arabia
        UAE
        Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Functional Dyspepsia Drug revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Functional Dyspepsia Drug revenues share in global market, 2022 (%)
Key companies Functional Dyspepsia Drug sales in global market, 2018-2023 (Estimated), (M Units)
Key companies Functional Dyspepsia Drug sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
    Bayer
    Sumitomo
    Cadila Pharmaceuticals
    Teva
    Johnson & Johnson
    Pfizer
    Sanofi
    AstraZeneca
    Jiangsu Aosaikang Pharma
    Eisai
    Kyowa Kirin Pharmaceuticals
    Hanmi Pharm
Outline of Major Chapters:
Chapter 1: Introduces the definition of Functional Dyspepsia Drug, market overview.
Chapter 2: Global Functional Dyspepsia Drug market size in revenue and volume.
Chapter 3: Detailed analysis of Functional Dyspepsia Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Functional Dyspepsia Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Functional Dyspepsia Drug capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.